Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPrUV: Antibiotic Prophylaxis in VCUG
NCT05438082Phase 4Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of trimethoprim and sulfamethoxazole in urinary tract infection (UTI) (2 arms), sponsored by Hamilton Health Sciences. Primary endpoint: Feasibility of pilot study at 12 months. Status: unknown.
02
Drugs
trimethoprimsulfamethoxazole
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05438082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05438082.